World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
113
Citations
42793
World Ranking
437
National Ranking
268

Medicine

D-Index
113
Citations
42871
World Ranking
4996
National Ranking
2710

Research.com Recognitions

  • 2009 - Fellow of the American Association for the Advancement of Science (AAAS)
  • 2005 - Oswald Avery Award, Infectious Diseases Society of America

Overview

James E. Crowe is affiliated with Vanderbilt University Medical Center in the United States. Their primary field of study is Medicine, with a significant focus on Infectious Diseases. Subfields of research include Epidemiology, Molecular Biology, Public Health, Environmental and Occupational Health, and Radiology, Nuclear Medicine and Imaging.

The scientist's research extensively covers topics related to viral infections and immunology. Major areas of work consist of:

  • SARS-CoV-2 and COVID-19 Research
  • Viral Infections and Vectors
  • Viral Infections and Outbreaks Research
  • Mosquito-borne Diseases and Control
  • Monoclonal and Polyclonal Antibodies Research
  • Viral Gastroenteritis Research and Epidemiology
  • Respiratory Viral Infections Research

Frequent coauthors collaborating with James E. Crowe include:

  • Robert H. Carnahan
  • Michael Diamond
  • Pavlo Gilchuk
  • Naveenchandra Suryadevara
  • Rachel E. Sutton

The researcher has published many papers in prestigious scientific journals and venues, with some of the main publication platforms being bioRxiv (Cold Spring Harbor Laboratory), UNC Libraries, Nature Communications, Cell Reports, and Cell.

Significant recent papers authored or co-authored by James E. Crowe include:

  • Potently neutralizing and protective human antibodies against SARS-CoV-2, 2020, Nature
  • Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition, 2020, Cell Host & Microbe
  • Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies, 2021, Nature Medicine
  • Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19, 2020, Nature Immunology
  • An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies, 2022, Nature Medicine

James E. Crowe has received professional recognition within the scientific community, including election as a Fellow of the American Association for the Advancement of Science (AAAS) in 2009 and the Oswald Avery Award from the Infectious Diseases Society of America in 2005.

Best Publications

  • Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children.

    John V. Williams;Paul A. Harris;Sharon J. Tollefson;Lisa L. Halburnt-Rush

  • Potently neutralizing and protective human antibodies against SARS-CoV-2.

    Seth J. Zost;Pavlo Gilchuk;James Brett Case;Elad Binshtein

  • Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition.

    Allison J. Greaney;Allison J. Greaney;Tyler N. Starr;Pavlo Gilchuk;Seth J. Zost

  • An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies

    Unknown

  • Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies.

    Rita E. Chen;Xianwen Zhang;James Brett Case;Emma S. Winkler

  • Structural Basis of Preexisting Immunity to the 2009 H1N1 Pandemic Influenza Virus

    Rui Xu;Damian C. Ekiert;Jens C. Krause;Rong Hai

  • Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19.

    Matthew C. Woodruff;Richard P. Ramonell;Doan C. Nguyen;Kevin S. Cashman

  • Proof of principle for epitope-focused vaccine design

    Bruno Emanuel F. Sousa Correia;John T. Bates;Rebecca J. Loomis;Gretchen Baneyx

  • Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors

    Xiaocong Yu;Tshidi Tsibane;Patricia A. McGraw;Frances S. House

  • Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein.

    Seth J. Zost;Pavlo Gilchuk;Rita E. Chen;James Brett Case

  • Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions.

    Ruklanthi De Alwis;Scott A. Smith;Nicholas P. Olivarez;William B. Messer

  • Mxra8 is a receptor for multiple arthritogenic alphaviruses

    Rong Zhang;Arthur S. Kim;Julie M. Fox;Sharmila Nair

  • Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice

    Gopal Sapparapu;Estefania Fernandez;Nurgun Kose;Bin Cao

  • Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape

    Unknown

  • Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy

    Peter F. Wright;Ruth A. Karron;Robert B. Belshe;Juliette Thompson

  • Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein.

    Naveenchandra Suryadevara;Swathi Shrihari;Pavlo Gilchuk;Laura A. VanBlargan

  • Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection.

    Emma S. Winkler;Pavlo Gilchuk;Jinsheng Yu;Adam L. Bailey

  • An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies

    Unknown

  • The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in non-human primates and has an extended half-life in humans

    Unknown

  • The Role of Human Metapneumovirus in Upper Respiratory Tract Infections in Children: A 20-Year Experience

    John V. Williams;Chiaoyin K. Wang;Chin-Fen Yang;Sharon J. Tollefson

  • High frequency of shared clonotypes in human B cell receptor repertoires

    Cinque Soto;Robin G. Bombardi;Andre Branchizio;Nurgun Kose

  • Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies

    Rodrigo Martino;Rocío Parody Porras;Nuria Rabella;John V. Williams

  • Towards a consensus on datasets and evaluation metrics for developing B-cell epitope prediction tools

    Jason A. Greenbaum;Pernille Haste Andersen;Martin Blythe;Huynh-Hoa Bui

  • Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes

    Ana Clara Monsalvo;Juan P Batalle;M Florencia Lopez;Jens C Krause

Frequent Co-Authors

Michael S. Diamond
Michael S. Diamond Washington University in St. Louis
Benjamin J. Doranz
Benjamin J. Doranz University of Pennsylvania
John V. Williams
John V. Williams University of Pittsburgh
Kathryn M. Edwards
Kathryn M. Edwards Vanderbilt University Medical Center
Jens Meiler
Jens Meiler Vanderbilt University
Andrew B. Ward
Andrew B. Ward Scripps Research Institute
Alexander Bukreyev
Alexander Bukreyev The University of Texas Medical Branch at Galveston
Erica Ollmann Saphire
Erica Ollmann Saphire La Jolla Institute For Allergy & Immunology
Aravinda M. de Silva
Aravinda M. de Silva University of North Carolina at Chapel Hill
Ian A. Wilson
Ian A. Wilson Scripps Research Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their expertise beyond Immunology, numerous related online degrees can pave the way to fulfilling healthcare careers. Many programs are designed with flexibility in mind, catering to diverse backgrounds and schedules.

Non-nurses seeking to enter the field may find online ABSN programs for non nurses particularly appealing. These programs accelerate the path to becoming registered nurses without requiring prior nursing experience, making them an efficient choice for career changers.

If access is a concern, exploring the easiest ABSN programs to get into can help candidates find schools with more inclusive admission criteria. This approach broadens opportunities for many aspiring healthcare professionals.

Similarly, those interested in practical nursing can benefit from researching LPN schools easy to get into, which provide quicker entry points into the nursing workforce.

For advanced practice roles, easiest nurse practitioner degree programs offer pathways that combine comprehensive training with accessible admissions, preparing graduates for specialized clinical care careers.

Overall, these related online degrees create diverse career pathways that complement Immunology studies, enabling professionals to contribute meaningfully to healthcare and patient outcomes.

Best Scientists Citing James E. Crowe

Trending Scientists